These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 28941830
1. Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler® dry powder inhaler. Farkas Á, Lewis D, Church T, Tweedie A, Mason F, Haddrell AE, Reid JP, Horváth A, Balásházy I. Int J Pharm; 2017 Nov 25; 533(1):225-235. PubMed ID: 28941830 [Abstract] [Full Text] [Related]
2. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers. Buttini F, Brambilla G, Copelli D, Sisti V, Balducci AG, Bettini R, Pasquali I. J Aerosol Med Pulm Drug Deliv; 2016 Apr 25; 29(2):167-78. PubMed ID: 26355743 [Abstract] [Full Text] [Related]
3. The effect of beclometasone dipropionate/formoterol extra-fine fixed combination on the peripheral airway inflammation in controlled asthma. Bulac S, Cimrin A, Ellidokuz H. J Aerosol Med Pulm Drug Deliv; 2015 Apr 25; 28(2):82-7. PubMed ID: 25050594 [Abstract] [Full Text] [Related]
4. Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler® Device in Healthy Subjects, Asthmatic Patients, and COPD Patients. Virchow JC, Poli G, Herpich C, Kietzig C, Ehlich H, Braeutigam D, Sommerer K, Häussermann S, Mariotti F. J Aerosol Med Pulm Drug Deliv; 2018 Oct 25; 31(5):269-280. PubMed ID: 29989511 [Abstract] [Full Text] [Related]
6. Computer modeling of airway deposition distribution of Foster(®) NEXThaler(®) and Seretide(®) Diskus(®) dry powder combination drugs. Jókay Á, Farkas Á, Füri P, Horváth A, Tomisa G, Balásházy I. Eur J Pharm Sci; 2016 Jun 10; 88():210-8. PubMed ID: 26976481 [Abstract] [Full Text] [Related]
7. Probing the particulate microstructure of the aerodynamic particle size distribution of dry powder inhaler combination products. Jetzer MW, Morrical BD, Schneider M, Edge S, Imanidis G. Int J Pharm; 2018 Mar 01; 538(1-2):30-39. PubMed ID: 29289516 [Abstract] [Full Text] [Related]
9. Numerical simulation of emitted particle characteristics and airway deposition distribution of Symbicort(®) Turbuhaler(®) dry powder fixed combination aerosol drug. Farkas Á, Jókay Á, Balásházy I, Füri P, Müller V, Tomisa G, Horváth A. Eur J Pharm Sci; 2016 Oct 10; 93():371-9. PubMed ID: 27552906 [Abstract] [Full Text] [Related]
10. Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler. Singh D, van den Berg F, Leaker B, Corradi M, Jabbal S, Collarini S, Mongelli V, Santoro L, Piccinno A, Biondaro S, Lipworth B. Br J Clin Pharmacol; 2019 Apr 10; 85(4):729-736. PubMed ID: 30586199 [Abstract] [Full Text] [Related]
17. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics. Popov TA, Petrova D, Kralimarkova TZ, Ivanov Y, Popova T, Peneva M, Odzhakova T, Ilieva Y, Yakovliev P, Lazarova T, Georgiev O, Hodzhev V, Hodzheva E, Staevska MT, Dimitrov VD. Pulm Pharmacol Ther; 2013 Dec 10; 26(6):624-9. PubMed ID: 23769863 [Abstract] [Full Text] [Related]
18. The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions. Farkas Á, Tomisa G, Kugler S, Nagy A, Vaskó A, Kis E, Szénási G, Gálffy G, Horváth A. Int J Pharm X; 2023 Dec 10; 5():100167. PubMed ID: 36824288 [Abstract] [Full Text] [Related]
20. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma. Gillissen A, Richter A, Oster H, Criée CP. J Physiol Pharmacol; 2007 Nov 10; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133 [Abstract] [Full Text] [Related] Page: [Next] [New Search]